RP
DGX icon

Riverwater Partners’s Quest Diagnostics DGX Stock Holding History

Riverwater Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
21,609
+636
+3% +$125K 1.36% 12
2026
Q1 		$4.11M Buy
20,973
+5,232
+33% +$1.02M 1.37% 11
2025
Q4 		$2.73M Buy
15,741
+2,160
+16% +$393K 1.06% 21
2025
Q3 		$2.59M Buy
13,581
+399
+3% +$70.8K 1.07% 23
2025
Q2 		$2.37M Sell
13,182
-31
-0.2% -$5.38K 1.12% 21
2025
Q1 		$2.24M Buy
13,213
+2,855
+28% +$469K 1.15% 20
2024
Q4 		$1.56M Buy
10,358
+152
+1% +$23.6K 0.76% 37
2024
Q3 		$1.58M Buy
10,206
+27
+0.3% +$4.03K 0.78% 36
2024
Q2 		$1.39M Sell
10,179
-56
-0.5% -$7.67K 1.03% 20
2024
Q1 		$1.36M Buy
10,235
+3,559
+53% +$462K 1% 21
2023
Q4 		$921K Buy
6,676
+45
+0.7% +$5.92K 0.73% 33
2023
Q3 		$808K Buy
6,631
+2,114
+47% +$282K 0.73% 34
2023
Q2 		$635K Buy
4,517
+204
+5% +$28.1K 0.56% 53
2023
Q1 		$610K Buy
4,313
+63
+1% +$9.01K 0.56% 53
2022
Q4 		$665K Buy
4,250
+194
+5% +$27.9K 0.57% 54
2022
Q3 		$498K Hold
4,056
– – 0.5% 63
2022
Q2 		$539K Buy
4,056
+284
+8% +$38.7K 0.54% 55
2022
Q1 		$516K Sell
3,772
-1,948
-34% -$272K 0.85% 53
2021
Q4 		$990K Buy
+5,720
New +$870K 0.88% 27

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Riverwater Partners's DGX Position: Q2 2026 in Review

Riverwater Partners increased its Quest Diagnostics (DGX) stake by 3% in Q2 2026, buying an estimated $125K and bringing the position to 21,609 shares worth $4.58M. The position accounts for 1.36% of the portfolio, ranked #12.

Riverwater Partners first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Riverwater Partners held 21,609 shares of Quest Diagnostics worth $4.58M as of Q2 2026.
  • Riverwater Partners bought 636 Quest Diagnostics shares in Q2 2026, an estimated $125K.
  • Quest Diagnostics made up 1.36% of Riverwater Partners's portfolio in Q2 2026, its #12 holding.
  • Riverwater Partners first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.